帮助 本站公告
您现在所在的位置:网站首页 > 知识中心 > 文献详情
文献详细Journal detailed

IL-27在急性冠脉综合征中的临床应用价值
Clinical application of interleukin-27 in the patients with acute coronary syndrome

作  者: (秦峰); (丁志祥); (李小龙); (孙毅); (虞丽娟); (季海刚); (张琪);

机构地区: 南京中医药大学附属常州市中医医院检验科,江苏常州213003

出  处: 《临床检验杂志》 2017年第8期609-611,共3页

摘  要: 目的探讨IL-27在急性冠脉综合征(ACS)中的临床应用价值。方法入选208例ACS患者,其中ST段抬高的心肌梗死(STEMI)76例、非ST段抬高的心肌梗死(NSTEMI)58例和不稳定心绞痛(UAP)74例;根据冠脉病变数分为单支、双支和三支病变组;以同期62例胸痛综合征(CPS)患者作为对照组。用酶联免疫吸附试验(ELISA)检测各组血浆IL-27的表达水平并进行统计学分析。结果与对照组100.66(68.98,228.86)pg/m L比较,STEMI组、NSTEMI组、UAP组血浆IL-27表达水平[分别为308.64(245.17,359.26)、256.88(181.52,332.51)、218.12(165.33,312.46)pg/m L]均明显升高(P均<0.01);组间两两比较结果表明,STEMI组血浆IL-27浓度明显高于NSTEMI组和UAP组(P均<0.05);,在TnI阴性的ACS患者中,IL-27阳性率为54.24%(32/59);IL-27在胸痛患者中预测ACS发生的敏感性和特异性分别为80.29%和58.06%。冠脉三支病变组IL-27表达水平明显高于单支病变组(P<0.05)。结论 IL-27在ACS患者外周血中表达明显升高,可能参与了ACS的发病机制。IL-27对TnI阴性的ACS患者以及ACS病情判断具有一定临床价值。 Objective To investigate the application value of interleukin-27( IL-27) in the patients with acute coronary syndrome( ACS). Methods A total of 208 ACS patients were enrolled in the study,including 76 acute myocardial infarction( AMI) patients with ST elevation( STEMI),58 AMI patients with non-ST elevation( NSTEMI) and 74 unstable angina pectoris( UAP) patients.These patients were divided into single-vessel lesions,double-vessel lesions and three-vessel lesions groups,and 62 patients with chest pain syndrome( CPS) were selected as a control group. The plasma IL-27 levels of all patients were determined by enzyme linked immunosorbent assay( ELISA) and analyzed. Results The levels of plasma IL-27( median[P25,P75]) in STEMI( 308. 64[245. 17,359. 26] pg/m L),NSTEMI( 256. 88[181. 52,332. 51] pg/m L) and UAP( 218. 12[165. 33,312. 46] pg/m L) patients were significantly higher than that in CPS patients( 100. 66[68. 98,228. 86] pg/m L,P〈0. 01). The levels of plasma IL-27 in STEMI patients were significantly higher than that in NSTEMI and UAP patients( P〈0. 05). The positive rate of IL-27 in ACS patients with negative Tn I was 54. 24%( 32/59). The sensitivity and specificity of IL-27 in predicting ACS from chest pain patients were 80. 29%and 58. 06%,respectively. The levels of plasma IL-27 in the patients with three-vessel lesions were significantly higher than that with single-vessel lesions( P〈0. 05). Conclusion Plasma IL-27 levels in ACS patients increase obviously,which may be involved in the pathogenesis of ACS. IL-27 may be helpful for the diagnosis of ACS patients with negative Tn I and the prediction of ACS state.

关 键 词: 急性冠脉综合征 肌钙蛋白

相关作者

相关机构对象

相关领域作者

作者 庞菊香
作者 康秋实
作者 康超
作者 廖伟导
作者 廖刚